PreprintAll rights reservedbioRxiv
Sodium butyrate inhibits the proliferation of temozolomide-resistant glioblastoma (A172) and lung adenocarcinoma (A549) cells and biphasically regulates EGFR expression
- 1Fukuoka University Faculty of Pharmaceutical Sciences
Related
- Decoy and antisense RNA oligonucleotides targeting the EGFR exon 3 splice site suppress proliferation of A172 glioblastoma cells
- Detection of Antagonistic Interactions Between Cannabidiol and Temozolomide in Various Neuroblastoma and Glioblastoma Cell Lines in the MTT Assay by Means of Synergy Finder 3.0 Software and Log-Probit Isobolographic Analysis
- Regulation of embryonic skeletal muscle satellite cell proliferation by CDK1 expression levels in goats
- Herboxidiene and EGFR expression in A172 glioblastoma cells
- Prognostic and Clinicopathological Significance of CD74 Expression in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
BibTeX
@misc{ishitsuka2026sodium,
title = {{Sodium butyrate inhibits the proliferation of temozolomide-resistant glioblastoma (A172) and lung adenocarcinoma (A549) cells and biphasically regulates EGFR expression}},
author = {M. Ishitsuka and Y. Horita and H. Harada and M. Mori and Y. Murata and K. Ohe},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.761832},
url = {https://www.biorxiv.org/content/10.64898/2026.10.26.761832v1},
}
RIS
TY - UNPB
TI - Sodium butyrate inhibits the proliferation of temozolomide-resistant glioblastoma (A172) and lung adenocarcinoma (A549) cells and biphasically regulates EGFR expression
AU - M. Ishitsuka
AU - Y. Horita
AU - H. Harada
AU - M. Mori
AU - Y. Murata
AU - K. Ohe
PY - 2026
DA - 2026/10/26
PB - bioRxiv
DO - 10.64898/2026.10.26.761832
UR - https://www.biorxiv.org/content/10.64898/2026.10.26.761832v1
ER -